Literature DB >> 7540235

Establishment of a new human cell line, LI90, exhibiting characteristics of hepatic Ito (fat-storing) cells.

K Murakami1, T Abe, M Miyazawa, M Yamaguchi, T Masuda, T Matsuura, S Nagamori, K Takeuchi, K Abe, M Kyogoku.   

Abstract

BACKGROUND: Thus far, human hepatic Ito (fat-storing) cell lines have not been established. Therefore, functional characteristics of Ito cells have not been fully investigated. EXPERIMENTAL
DESIGN: We established a new cell line, LI90, that exhibited characteristics compatible with those of Ito cells from a human hepatic mesenchymal tumor. LI90 cells were examined with phase-contrast microscopy, immunohistochemistry, and cytogenetics, and their vitamin A-storing activity was analyzed. To obtain a marker specific for Ito cells for immunohistochemical analyses, we raised mAb against LI90 cells and clarified the molecular nature of the Ag recognized with the new Ab using an expression cloning approach.
RESULTS: LI90 cells showed polygonal shape and had well developed alpha-smooth muscle actin filaments in their cytoplasm. In an overconfluent culture condition, LI90 cells aggregated to form a typical hills-and-valleys structure, LI90 cells produced various connective tissue components, such as collagen types I, III, IV, V, and VI, laminin, and fibronectin. In culture media containing vitamin A, LI90 cells formed many fat droplets in their cytoplasm, and fluorescence characteristic of vitamin A was observed in the droplets. By immunizing mice with LI90 cells, three separate mAb specifically reacting with Ito cells in human liver sections were established, and the Ag recognized with all three Ab were identified as extracellular matrix tenascin.
CONCLUSIONS: The above-described morphologic and functional characteristics, including vitamin A-storage and biosynthesis of tenascin, are compatible with those of Ito cells. Therefore, LI90 cells will be useful for in vitro studies of functions of human Ito cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7540235

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  14 in total

Review 1.  Gene modulation for treating liver fibrosis.

Authors:  Kun Cheng; Ram I Mahato
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  2007       Impact factor: 4.889

2.  Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis.

Authors:  L Xu; A Y Hui; E Albanis; M J Arthur; S M O'Byrne; W S Blaner; P Mukherjee; S L Friedman; F J Eng
Journal:  Gut       Date:  2005-01       Impact factor: 23.059

3.  Growth arrest and decrease of alpha-SMA and type I collagen expression by palmitic acid in the rat hepatic stellate cell line PAV-1.

Authors:  Armand Abergel; Vincent Sapin; Nicolas Dif; Christophe Chassard; Claude Darcha; Julie Marcand-Sauvant; Brigitte Gaillard-Martinie; Edmond Rock; Pierre Dechelotte; Patrick Sauvant
Journal:  Dig Dis Sci       Date:  2006-04-27       Impact factor: 3.199

4.  Angiotensin II participates in hepatic inflammation and fibrosis through MCP-1 expression.

Authors:  Keishi Kanno; Susumu Tazuma; Tomoji Nishioka; Hideyuki Hyogo; Kazuaki Chayama
Journal:  Dig Dis Sci       Date:  2005-05       Impact factor: 3.199

Review 5.  Human hepatic stellate cell isolation and characterization.

Authors:  Linshan Shang; Mojgan Hosseini; Xiao Liu; Tatiana Kisseleva; David Allen Brenner
Journal:  J Gastroenterol       Date:  2017-11-01       Impact factor: 7.527

6.  Interferon-β Mediates Signaling Pathways Uniquely Regulated in Hepatic Stellate Cells and Attenuates the Progression of Hepatic Fibrosis in a Dietary Mouse Model.

Authors:  Rieko Shimozono; Kazumi Nishimura; Hideo Akiyama; Saeko Funamoto; Akiko Izawa; Takafumi Sai; Kana Kunita; Mie Kainoh; Tomohiko Suzuki; Norifumi Kawada
Journal:  J Interferon Cytokine Res       Date:  2015-02-25       Impact factor: 2.607

7.  Advanced glycation end products enhance the proliferation and activation of hepatic stellate cells.

Authors:  Keiko Iwamoto; Keishi Kanno; Hideyuki Hyogo; Sho-Ichi Yamagishi; Masayoshi Takeuchi; Susumu Tazuma; Kazuaki Chayama
Journal:  J Gastroenterol       Date:  2008-05-06       Impact factor: 7.527

8.  Hepatitis C virus infection induces inflammatory cytokines and chemokines mediated by the cross talk between hepatocytes and stellate cells.

Authors:  Hironori Nishitsuji; Kenji Funami; Yuko Shimizu; Saneyuki Ujino; Kazuo Sugiyama; Tsukasa Seya; Hiroshi Takaku; Kunitada Shimotohno
Journal:  J Virol       Date:  2013-05-15       Impact factor: 5.103

Review 9.  Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver.

Authors:  Scott L Friedman
Journal:  Physiol Rev       Date:  2008-01       Impact factor: 37.312

10.  Novel organotypic culture model of cholangiocarcinoma progression.

Authors:  Deanna J W Campbell; Catherine I Dumur; Nadia F Lamour; Jennifer L Dewitt; Alphonse E Sirica
Journal:  Hepatol Res       Date:  2012-05-09       Impact factor: 4.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.